0000950170-24-008020.txt : 20240126 0000950170-24-008020.hdr.sgml : 20240126 20240126171005 ACCESSION NUMBER: 0000950170-24-008020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240124 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILSON TROY EDWARD CENTRAL INDEX KEY: 0001589597 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 24568855 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 ownership.xml 4 X0508 4 2024-01-24 0001422143 Kura Oncology, Inc. KURA 0001589597 WILSON TROY EDWARD C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 true true false false President and CEO false Common Stock 2024-01-24 4 M false 6945 4.80 A 7504 D Common Stock 2024-01-24 4 S false 6945 20.23 D 559 D Common Stock 2024-01-24 4 M false 84107 6.15 A 84666 D Common Stock 2024-01-24 4 S false 84107 20.23 D 559 D Common Stock 300000 I by Lorax Charitable Remainder Unitrust Common Stock 279194 I by One Fish Two Fish Revocable Trust These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022. Teresa Bair, Attorney-in-fact for Troy E. Wilson 2024-01-26